Embecta Receives 510(K) Clearance From FDA For Its Proprietary Disposable Insulin Delivery System

Embecta獲得FDA對其專有的一次性胰島素輸送系統的510(K)清關

Benzinga · 2024/09/03 18:31

Indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D), the system includes a tubeless patch pump design with a 300-unit insulin reservoir that was informed by feedback from people with T2D and their healthcare providers.

適用於需要胰島素控制糖尿病的成年人，包括1型糖尿病（T1D）和2型糖尿病（T2D），該系統採用了一個無管路貼片泵設計，帶有一個300單位胰島素儲水器，該設計是根據T2D患者和他們的醫療服務提供者的反饋進行的。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Embecta Receives 510(K) Clearance From FDA For Its Proprietary Disposable Insulin Delivery System

Embecta Receives 510(K) Clearance From FDA For Its Proprietary Disposable Insulin Delivery System

風險及免責聲明

聲明